Trials / Completed
CompletedNCT03017235
A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
A Randomized, Assessor-Blinded, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution Versus Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Powder for Oral Solution (PREPOPIK®) for Colon Cleansing in Preparation for Colonoscopy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 917 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution with PREPOPIK® for colon cleansing in adult subjects undergoing colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution | Supplied as two 160 mL ready-to-drink bottles, per subject, without further reconstitution, before administration. |
| DRUG | Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Powder | Supplied as two sachets per subject. Subjects will be instructed to reconstitute the medication by combining the contents of one packet with approximately five (5) ounces of cold water and stirring for two to three minutes. |
Timeline
- Start date
- 2017-02-20
- Primary completion
- 2017-09-15
- Completion
- 2017-10-12
- First posted
- 2017-01-11
- Last updated
- 2018-11-14
- Results posted
- 2018-11-14
Locations
14 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03017235. Inclusion in this directory is not an endorsement.